The effect of the radial function on I-125 seeds used for permanent prostate implantation

Medical Dosimetry

Volumn 29, Issue 3, 2004, Pages 204-209

  Pickett, Barby ^a   Pouliot, Jean ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anisotropy; Dose rate constant; Permanent prostate implant; Radial function; Seed activity; Seed model comparison

Indexed keywords

IODINE 125; SILVER;

ANISOTROPY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; DRUG MEGADOSE; EVALUATION; HEALTH CARE PLANNING; HISTOGRAM; HUMAN; IMPLANT; IMPLANTATION; NEEDLE; ORGAN SIZE; PENIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE; RADIATION DOSE DISTRIBUTION; RECTUM; URETHRA;

ANISOTROPY; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IODINE RADIOISOTOPES; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES;

EID: 8444251318     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2004.03.018     Document Type: Article

References (15)

1. Blasko J.C., Grim P.D., Ragde H., Schumacher D. Implant therapy for localized prostate cancer. Ernstoff M.S., Heaney J.A., Peschel R.E. Prostate Cancer. 1998;137-155 Blackwell Science, Cambridge; MA
2. Speight J., Pickett B., Roach M. Prostate volume change after radioactive seed implantation possible benefit of improved dose volume histogram with perioperative steroid. Int. J. Radiat. Oncol. Biol. 48:2000;1461-1467
3. Nath R., Anderson L., Luxton G., Weaver K. Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med. Phys. 22:1995;209-234
4. Kubo D., Coursey B., Hanson W., Kline R.W. Report of the Ad Hoc Committee of the AAPM Radiation Therapy Committee on I-125 Sealed Source Dosimetry. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;697-702
5. Anderson L.L., Shipley W.U. Dose inhomogeneity in interstitial implants using I-125 seeds. Int. J. Radiat. Oncol. Biol. Phys. 5:1979;419-425
6. Ling C.C., Schell M.C., Yorke E.D. Two-dimensional dose distribution of I-125 seeds. Med. Phys. 12:1985;652-655
7. Schell M.C., Ling C.C., Cromadzki Z.C., Werking K.R. Dose distributions of model 6702 I-125 seeds in water. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;795-799
8. Williams J., et al. Guidance to users of Nycomed-Amersham and North American Scientific, Inc., I-125 Interstitial Sources: Dosimetry and calibration changes: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry. Med. Phys. 26:1999;570-573
9. Hedtjarn H., Carlsson G., Williamson J. Monte Carlo-aided dosimetry of the symmetra model 125.So6 I-125, interstitial brachytherapy seed. Med. Phys. 27:2000;1076-1085
10. Kirov A., Williamson J. Monte Carlo-Aided dosimetry of the Source Tech Medical I-125 interstitial brachytherapy seed. Med. Phys. 27:2000;132
11. Wallace R. Empirical dosimetric characterization of model I125-SL I-125 brachytherapy source in phantom. Med. Phys. 27:2000;2796-2802
12. Bice W.S., Prestidge B.R., Prete J.J., Dubois D.F. Clinical impact of implementing AAPM Task Group 43 on permanent prostate brachytherapy using I-125. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;1237-1241
13. Alzitzoglou T. The half life of I-125. Applied Radiat. Isotopes. 42:1991;493
14. Heintz B., Wallace R., Hevezi J. Comparison of I-125 sources for permanent interstitial implants. Med. Phys. 28:2000;671-682
15. Taschereau R., Roy R., Pouliot J. RBE enhancement of an I-125 brachytherapy seed. Med. Phys. 29:2002;1397-1402